Author:
Konovalova V N,Smetnik V P,Konovalova V N,Smetnik V P
Abstract
The paper provides an epidemiological update on a risk for breast cancer during menopausal hormone replacement therapy. It gives the results of large observational and randomized clinical trials, as well as the point of view of the International Menopause Society in the context of evidence-based medicine.
Reference27 articles.
1. American Cancer Society. Breast cancer facts and figures 2003-2004. http://www.cancer.org/downloads/STT/ CAFF2003BrFPWSecured.pdg.
2. Black W. C., Welch H. G. // N. Engl. J. Med. - 1993. - Vol. 328. - P. 1237-1243.
3. Chen C. L. et al. // J. A. M. A. - 2002. - Vol. 287. - P. 734- 741.
4. Chlebowski R. T. et al. // J. A. M. A. - 2003. - Vol. 289. - P. 3243-3253.
5. Colditz G. A. et al. // N. Engl. J. Med. - 1995. - Vol. 330. - P. 1589-1599.